Manuel Haas - European Medicines Agency

基本信息

浏览量：7

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 12 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Reducing valproate use in women with epilepsy

Reetta Kälviäinen,Sabine Straus,Jean-Michel Dogné,Serge Bakchine,Manuel Haas

The Lancet Neurologyno. 7 (2018): 580-581

引用5浏览0WOS引用

Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues

Annemieke Aartsma-Rus,Volker Straub,Robert Hemmings,Manuel Haas,Gabriele Schlosser-Weber,Violeta Stoyanova-Beninska,Eugenio Mercuri,Francesco Muntoni,Bruno Sepodes,Elizabeth Vroom,Pavel Balabanov

NUCLEIC ACID THERAPEUTICS（2017）

引用132浏览0WOS引用

132

Stakeholder collaboration for spinal muscular atrophy therapy development

Annemieke Aartsma-Rus,Pavel Balabanov,Luca Binetti,Manuel Haas,Marion Haberkamp, Joanna Mitchell,Mário M. Rosa,Francesco Muntoni,Richard S. Finkel,Eugenio Mercuri

The Lancet Neurologyno. 4 (2017): 264-264

引用11浏览0WOS引用

The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use

Marta Kollb-Sielecka,Pierre Demolis, Joseph Emmerich,Greg Markey,Tomas Salmonson,Manuel Haas

Sleep medicine（2017）

引用73浏览0WOS引用

Drug‐induced Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: European Regulators' Perspective

R Anton,M Haas,P Arlett, M Weise, P Balabanov,G Mazzaglia,L Prieto,B Keller-Stanislawski,J Raine

Clinical pharmacology and therapeuticsno. 2 (2017): 283-289

引用18浏览0WOS引用

Challenges in Drug Development for Central Nervous System Disorders: a European Medicines Agency Perspective

Florence Butlen-Ducuing,Frank Pétavy,Lorenzo Guizzaro,Malgorzata Zienowicz,Tomas Salmonson,Manuel Haas,Emmanuelle Corruble,Enrica Alteri

Nature Reviews Drug Discovery（2016）

引用28浏览0引用

European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene

Manuel Haas,Viktor Vlcek,Pavel Balabanov,Tomas Salmonson,Serge Bakchine,Greg Markey,Martina Weise,Gabriele Schlosser-Weber,Henning Brohmann,Concepcion Prieto Yerro,Macarena Rodriguez Mendizabal,Violeta Stoyanova-Beninska,Hans L Hillege

Neuromuscular Disorders（2015）

引用130浏览0WOS引用

130

The European Medicines Agency's strategies to meet the challenges of Alzheimer disease

Manuel Haas,Valentina Mantua,Marion Haberkamp,Luca Pani,Maria Isaac,Florence Butlen-Ducuing,Spiros Vamvakas,Karl Broich

NATURE REVIEWS DRUG DISCOVERY（2015）

引用13浏览0WOSNATURE引用

Addressing the Regulatory and Scientific Challenges in Multiple Sclerosis--a Statement from the EU Regulators

Pavel Balabanov,Manuel Haas,Andre Elferink,Serge Bakchine,Karl Broich

Multiple sclerosis（2014）

引用8浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn